Carlsmed, Inc.

Carlsmed is a commercial-stage medical technology company pioneering AI-enabled personalized spine surgery solutions, with a mission to improve patient outcomes and reduce healthcare costs in spine surgery and beyond. The company is focused on establishing its technology as the standard of care for spine fusion procedures.

Carlsmed’s proprietary aprevo® Technology Platform integrates artificial intelligence (AI)-enabled software, custom-designed interbody implants tailored to each patient’s unique pathology and vertebral bone topography, and single-use surgical instruments. Developed to overcome the limitations of traditional spine fusion surgery, the aprevo Platform is designed to optimize clinical outcomes and reduce the need for revision surgeries.

By delivering personalized surgical plans and AI-powered, outcomes-based implant designs, the aprevo Technology Platform helps surgeons achieve optimal spinal alignment for patients with degenerative disc disease (DDD), thereby improving results and minimizing the likelihood of additional procedures. Carlsmed currently markets the aprevo Platform for lumbar spine fusion surgery and is actively developing the system for cervical spine fusion procedures, with commercialization expected in 2026.